Methods of treating autoimmune diseases with gp39-specific antibodies

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Idec Pharmaceuticals Corporation patent solves the following problem:

The immune system is capable of producing two types of antigen-specific response to foreign antigens. Cell-mediated immunity is the term used to refer to effector functions of the immune system mediated by T lymphocyte. Humoral immunity is the term used to refer to the production of antigen-specific antibody in the B lymphocyte. It has long been appreciated that the development of humoral immunity against most antigens requires not only antibody-producing B lymphocytes but also the involvement of helper T (called th) lymphocyte. (Mitchison, EUR J. Immunol, 1: 18-25 (1971); Claman and Chaperon, Transplant Pin, 1: …… 92-119 (1969); Katz et al, Proc Natl Acad Sci USA, 70 : 2624-2629 (1973); Reff et al, Nature, 226: 1257-1260 (1970)). Some signal, or assistance given by Th cells in response to stimulation by Thymus-dependent (called TD) antigens. While some B lymphocyte help mediated by soluble molecules released by Th cells (for instance lymphokines such as IL-4 and IL-5), activation of B cells also requires a contact-dependent interaction between cells B cells and th. (Hirohata et al, J. Immunol, 140: 3736-3744 (1988); Bartlett et al, J. Immunol, 143: 1745-1765 (1989)). This indicates that B cell activation involves an obligatory interaction between cell surface molecules on B cells and cells th. Such an interaction further supported by the observation that isolated plasma membranes of activated T cells can provide helper functions necessary for B cell activation. (Brian, Proc Natl Acad Sci USA, 85: 564-568 (1988); Hodgkin et al, J. Immunol, 145: …… 2025-2034 (1990); Noelle et al, J. Immunol, 146 : 1118-1124 (1991)).

Our analysis of this patent is as follows:

Idec Pharmaceuticals Corporation’s patent US 6440418 B1 deals with Methods of treating autoimmune diseases with gp39-specific antibodies.
The present invention is directed to humanized antibodies that bind to human GP39 and their use as therapeutic agents. These humanized antibody particularly useful for the treatment of autoimmune diseases; and an immunosuppressant during transplantation of heterologous cells, tissues or organs, cell therapy and gene therapy.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and systems for treating ischemia

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Salient Interventional Systems, Inc. patent solves the following problem:

The present invention relates generally to medical devices and procedures. Particularly, the present invention relates to catheter systems, kits, and methods for treating ischemia, intracerebral ischemia associated with stroke.

Our analysis of this patent is as follows:

Salient Interventional Systems, Inc.’s patent US 6435189 B1 deals with Methods and systems for treating ischemia.
Methods for treating general and partial occlusions use a perfusion channel that entered through the occlusive material. Oxygenated blood or other medium then perfused through the conduit in a controlled manner, preferably at a controlled pressure under arterial pressure, to maintain oxygenation and relieve ischemia in tissues distal to the occlusion. On the other hand, interventional devices, such as stents or balloon catheter, passed through the perfusion catheter to remove obstacles. Optionally, the occlusion can be treated as perfusion remain, mostly by introducing a thrombolytic agent or other occlusive material to use in perfusion channel or by using mechanical means to remove the obstacles. The method is especially suitable for the treatment of acute stroke to prevent damage to the cerebral tissue.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Link-level flow control method for an ATM server

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Telefonaktiebolaget L M Ericsson (Publ) patent solves the following problem:

Our analysis of this patent is as follows:

Telefonaktiebolaget L M Ericsson (Publ)’s patent US 6438104 B1 deals with Link-level flow control method for an ATM server.
A link-level flow control strategy for the service of ATM cell streams coming from a number of sources package determines a desired bandwidth component for each source packages and lining ATM cells to Income from the source package in a shared FIFO buffer. Based on the number of transmitted ATM cells in a pre-defined period of time, not offering the source packages and source packages violations identified. The non-violation of the package source is the source package during the predefined period of time does not require much more than their requested bandwidth portion, and the violation of the package source is the source package in the same period requires more time than desired bandwidth part. To maintain justice between the source packages, the non-violation of the package source gave no more than a request bandwidth of, with the remaining bandwidth is not given to the non-violation of source package given to the violation of the source package.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Alignment free methodology for rapid determination of differences between a test data set and known data sets

File for Quick & Easy Patent Protection with PowerPatent.

The International Business Machines Corporation patent solves the following problem:

It is known that there are various deficiencies in existing procedures related to certain applications in bioinformatics and computational genomics. These deficits are of increasing concern as the coating of genomic data. Of particular concern in the current algorithms designed to detect similar protein sequences to a known database given a probation order. For example, many of the existing algorithms fully or clearly requires an array keeping operations despite the fact that it is desirable to avoid such an operation. Furthermore, none of the current algorithms especially well suited for the efficient use of a relationship in data base. Still further, the present methods of protein search and file-pattern recognition depends on very complex mathematical procedures.

Our analysis of this patent is as follows:

International Business Machines Corporation’s patent US 6434488 B1 deals with Alignment free methodology for rapid determination of differences between a test data set and known data sets.
A method for generating data indicative of something described in a command string of characters, comprising the steps of: (i) for a set of metrics divorce each representing a unique number of duties separation between arbitrary character of a group of behavior in the ordered string of characters, in association with each separate metric; creating a set of character groups, where each group of character composed of at least two characters within the rule string of characters; and (ii) for at least a given group of nature set of group behavior, for each separate metric given set of metrics separation, a second data representing the number of texts given the nature of the group satisfies the given separation metric; generating third data associated with the given group behavior, where the third data base on the second data and the first data; and gathering data to third memory after use.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Optical switch

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Alcatel patent solves the following problem:

Usually, optical switching designed to selectively directing one or more optical signal received from one or more transmission lines to other lines as a function of a command. switch may be a space-division switch. It can also be a time-division switch, ie able to selectively delaying the input signal by the length that vary as a function of command. Time-division transfer used in particular to resolve conflicts in the package-transfer system.

Our analysis of this patent is as follows:

Alcatel’s patent US 6433902 B1 deals with Optical switch.
A switch to avoid giving interference noise, limiting speed of communication, and giving loss, including n passive couplers, each one given a number k outlets, and with a mouth suitable for receiving an input signal; and k wavelength multiplexers, each of which n bay placed in each of the n wavelength. For each multiplexer, one of his bay placed in one of the wavelength, accompanied by a deploys optical gate to one of the outlets in one of the couplers were organized to receive an input signal carried on same wavelength. switch used to make routing functions in communications networks with optical links.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Process and apparatus for high flow and low pressure impurity removal

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Microbar Incorporated patent solves the following problem:

Many manufacturing operations to generate plenty of water containing heavy metals and other inorganic and organic contamination. These industries include, but are not limited to, agriculture, petroleum, chemical, medical, mining, metal plating, metal finishing, textiles, pulp / paper, brewing, beverage, distilling, food processing, and semiconductor industries. This industry is strictly regulated on the level of contamination in discharged wastewater. This is a result of toxicity problems because of contamination of waterways with heavy metals, suspended solids, and organic materials. Strict limits adopted for discharge of heavy metal contamination is considered harmless to humans and marine organisms, and include cadmium, chromium, copper, lead, mercury, nickel, zinc, and semi-metals such as arsenic and selenium. discharge limit is also in many other industries. Discharge wastewater containing large amounts of suspended solids is harmful to ecosystems because of silting and reduced the availability of light for photosynthesis.

Our analysis of this patent is as follows:

Microbar Incorporated’s patent US 6428705 B1 deals with Process and apparatus for high flow and low pressure impurity removal.
A process of getting contamination from large volumes of contaminated water exposed. The process involves treating a wastewater stream containing harmful elements in a coagulant reaction to harmful elements in the form of an impurity or aggregate, particulates having a size greater than 10 m. The treated wastewater is passed through a microfiltration membrane with a pore size in the range from 0.5 m to 10 m at low pressure (less than 20 psig) to remove harmful elements. Under such circumstances, the treated wastewater discharge rate is greater than 200 gallons per square foot of membrane per day (GFD), and usually from 200 to 1500 GFD.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and computer program for displaying quantitative data

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Charles V. Dehner, Jr., , Wayne Hewitt patent solves the following problem:

The present invention relates to the display and analysis of quantitative data. Particularly, the invention relates to a method and computer program for the simultaneous display of very large set of quantitative data without first standardizing or conditioning in the data, while allowing viewers to easily identify individual variables and values ​​in the display, and allow extensive control over a color mapping process.

Our analysis of this patent is as follows:

Charles V. Dehner, Jr., , Wayne Hewitt’s patent US 6429868 B1 deals with Method and computer program for displaying quantitative data.
A method and computer program for the simultaneous display of very large set of quantitative data. The methods and computer programs allow the display of quantitative data without first standardizing the data. The methods and computer programs also allow an observer to display data in the space below the user controlled color, choosing color spectrums to highlight or hide certain data or certain characteristics, and moving up and fly through space data to identify and analyze areas of interest.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.